{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T11:13:50Z","timestamp":1780658030519,"version":"3.54.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007195","name":"Federico II University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007195","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010114","name":"Yrj\u00f6 Jahnsson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004037","name":"Juho Vainio Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004037","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007083","name":"Orion Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007083","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["308248"],"award-info":[{"award-number":["308248"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["312073"],"award-info":[{"award-number":["312073"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland Centre of Excellence in Research on Mitochondria, Metabolism and Disease","doi-asserted-by":"publisher","award":["272376"],"award-info":[{"award-number":["272376"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland research","doi-asserted-by":"publisher","award":["314383"],"award-info":[{"award-number":["314383"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland research","doi-asserted-by":"publisher","award":["266286"],"award-info":[{"award-number":["266286"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Finnish Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013500","name":"Finnish Diabetes Research Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100013500","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Gyllenberg Foundation"},{"DOI":"10.13039\/501100005633","name":"Finnish Foundation for Cardiovascular Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007797","name":"University of Helsinki","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007797","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008376","name":"Helsinki University Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Government Research Funds"},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.numecd.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T12:17:59Z","timestamp":1571141879000},"page":"459-466","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A higher glycemic response to oral glucose is associated with higher plasma apolipoprotein C3 independently of BMI in healthy twins"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6549-4476","authenticated-orcid":false,"given":"Lutgarda","family":"Bozzetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram J.","family":"Berntzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Kaprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aila","family":"Rissanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marja-Riitta","family":"Taskinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi H.","family":"Pietil\u00e4inen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2019.10.005_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11883-016-0614-1","article-title":"Why is apolipoprotein CIII emerging as a novel therapeutic target to reduce the burden of cardiovascular disease?","volume":"18","author":"Taskinen","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.numecd.2019.10.005_bib2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI119456","article-title":"Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein E","volume":"99","author":"Ebara","year":"1997","journal-title":"J Clin Investig"},{"key":"10.1016\/j.numecd.2019.10.005_bib3","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1161\/ATVBAHA.115.305614","article-title":"Kinetic and related determinants of plasma triglyceride concentration in abdominal obesity: multicenter tracer kinetic study","volume":"35","author":"Bor\u00e9n","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2019.10.005_bib4","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.2337\/dc16-0126","article-title":"Antisense-mediated lowering of plasma apolipoprotein C-III by volanesorsen improves dyslipidemia and insulin sensitivity in type 2 diabetes","volume":"39","author":"Digenio","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2019.10.005_bib5","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2337\/dc16-1295","article-title":"Serum levels of apolipoproteins and incident type 2 diabetes: a prospective cohort study","volume":"40","author":"Brahimaj","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2019.10.005_bib6","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s00125-011-2092-x","article-title":"Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons","volume":"54","author":"van Hoek","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2019.10.005_bib7","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/aje\/kwx143","article-title":"C-III and high-density lipoprotein subspecies defined by apolipoprotein C-III in relation to diabetes risk","volume":"186","author":"Aroner","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2019.10.005_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-8-3","article-title":"Role of MAPK in apolipoprotein CIII-induced apoptosis in INS-1E cells","volume":"8","author":"Sol","year":"2009","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2019.10.005_bib9","doi-asserted-by":"crossref","first-page":"E2611","DOI":"10.1073\/pnas.1423849112","article-title":"Apolipoprotein CIII links islet insulin resistance to \u03b2-cell failure in diabetes","volume":"112","author":"\u00c5vall","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.numecd.2019.10.005_bib10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1161\/ATVBAHA.110.220723","article-title":"Transcriptional activation of apolipoprotein CIII expression by glucose may contribute to diabetic dyslipidemia","volume":"31","author":"Caron","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.numecd.2019.10.005_bib11","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1172\/JCI200419992","article-title":"Foxo1 mediates insulin action on apoC-III and triglyceride metabolism","volume":"114","author":"Altomonte","year":"2004","journal-title":"J Clin Investig"},{"key":"10.1016\/j.numecd.2019.10.005_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3945\/ajcn.117.153643","article-title":"Differences in genetic and environmental variation in adult BMI by sex, age, time period, and region: an individual-based pooled analysis of 40 twin cohorts","volume":"106","author":"Silventoinen","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2019.10.005_bib13","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3945\/ajcn.116.130252","volume":"104","author":"Silventoinen","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2019.10.005_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.numecd.2019.10.005_bib15","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.numecd.2019.10.005_bib16","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/s41588-018-0084-1","article-title":"Refining the accuracy of validated target identification through coding variant fine-mapping in type 2 diabetes","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/j.numecd.2019.10.005_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/thg.2012.142","article-title":"The Finnish twin cohort study: an update","volume":"16","author":"Kaprio","year":"2013","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/j.numecd.2019.10.005_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ijo.2011.192","article-title":"Causes and consequences of obesity: the contribution of recent twin studies","volume":"36","author":"Naukkarinen","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.numecd.2019.10.005_bib19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/nbm.1580","article-title":"Long-TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat","volume":"24","author":"Lundbom","year":"2010","journal-title":"NMR Biomed"},{"key":"10.1016\/j.numecd.2019.10.005_bib20","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2011.12.023","article-title":"Epicardial fat, cardiac dimensions, and low-grade inflammation in young adult monozygotic twins discordant for obesity","volume":"109","author":"Gran\u00e9r","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2019.10.005_bib21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2019.10.005_bib22","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2019.10.005_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc06-1519","article-title":"Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test","volume":"30","author":"Abdul-Ghani","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2019.10.005_bib24","doi-asserted-by":"crossref","first-page":"368","DOI":"10.2337\/diabetes.41.3.368","article-title":"Estimation of insulin secretion rates from C-peptide levels. Comparison of individual and standard kinetic parameters for C-peptide clearance","volume":"41","author":"Van Cauter","year":"1992","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2019.10.005_bib25","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/j.1464-5491.2009.02841.x","article-title":"Evaluation of proposed oral disposition index measures in relation to the actual disposition index","volume":"26","author":"Retnakaran","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/j.numecd.2019.10.005_bib26","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1172\/JCI103182","article-title":"The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum","volume":"34","author":"Havel","year":"1955","journal-title":"J Clin Investig"},{"key":"10.1016\/j.numecd.2019.10.005_bib27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0005-2760(81)90253-8","article-title":"Characterization of human high-density lipoproteins by gradient gel electrophoresis","volume":"665","author":"Blanche","year":"1981","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.numecd.2019.10.005_bib28","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0022-2275(20)31585-6","article-title":"A new method for HDL particle sizing by polyacrylamide gradient gel electrophoresis using whole plasma","volume":"42","author":"P\u00e9russe","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1016\/j.numecd.2019.10.005_bib29","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2188\/jea.JE20081037","article-title":"Heritability of serum apolipoprotein concentrations in middle-aged Japanese twins","volume":"19","author":"Cai","year":"2009","journal-title":"J Epidemiol"},{"key":"10.1016\/j.numecd.2019.10.005_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(87)90173-0","article-title":"Lifestyle factors affecting intrapair differences of serum apoproteins and cholesterol concentrations in adult identical twins","volume":"66","author":"Hayakawa","year":"1987","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2019.10.005_bib31","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm.4390","article-title":"A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels","volume":"23","author":"Khetarpal","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.numecd.2019.10.005_bib32","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa1308027","article-title":"Loss-of-function mutations in APOC3 and risk of ischemic vascular disease","volume":"371","author":"J\u00f8rgensen","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.numecd.2019.10.005_bib33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1307095","article-title":"Loss-of-function mutations in APOC3, triglycerides, and coronary disease","volume":"371","author":"TG and HDL Working Group of the Exome Sequencing Project","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2019.10.005_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2174\/1871529X11202020133","article-title":"Human apolipoprotein C-III - a new intrahepatic protein factor promoting assembly and secretion of very low density lipoproteins","volume":"12","author":"Yao","year":"2012","journal-title":"Cardiovasc Haematol Disord - Drug Targets"},{"key":"10.1016\/j.numecd.2019.10.005_bib35","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2337\/diabetes.55.03.06.db05-1380","article-title":"Susceptibility to type 1 diabetes is associated with ApoCIII gene haplotypes","volume":"55","author":"Hokanson","year":"2006","journal-title":"Diabetes"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475319303862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475319303862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:10:19Z","timestamp":1760544619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475319303862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0939475319303862"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2019.10.005","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A higher glycemic response to oral glucose is associated with higher plasma apolipoprotein C3 independently of BMI in healthy twins","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V. on behalf of The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}]}}